Elevance Health Inc (ELV)
Elevance Health Inc (ELV) carries a ŷRobot AI score of 69 out of 100. The model's fair value estimate is $447.37, 4.5% above the last close of $428.10. The chart signal reads Sell.
| Metric | ELV |
|---|---|
| AI score | 69 / 100 |
| Chart signal | Sell |
| Fair value estimate | $447.37 |
| Upside to fair value | 4.5% |
| Previous close | $428.10 |
| P/E | 17.18 |
| Price / sales | 0.41 |
| Market cap | $91.54B |
| EPS | 22.63 |
| Revenue growth | 7.6% |
| 1-year price change | 6.1% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about ELV
Is ELV overvalued or undervalued right now?
As of Oct 14, 2026, ŷRobot's fair-value model estimates Elevance Health Inc (ELV) at $447.37 against a last close of $428.10, implying 4.5% upside to the model's estimate.
Is ELV's chart signal bullish or bearish?
The chart-signal model classifies ELV as Neutral as of Oct 14, 2026, with a signal score of -0.14 on a -1 to 1 scale.
What is ELV's ŷRobot AI score?
ELV scores 69 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 14, 2026.
Is ELV stock expensive on P/E and P/S?
ELV trades at 17.2 times earnings and 0.4 times sales as of Oct 14, 2026.
What does ELV's seasonal forecast show?
ŷRobot's seasonal forecast curve for ELV reads +3.4% at 30 days, +6.2% at 90 days, and +6.1% at one year as of Oct 14, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is ELV growing?
Elevance Health Inc's revenue growth is +7.6% and free-cash-flow growth is +18.4% on the latest reported figures.
ELV chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.